DMTC is calling for expressions of interest for Round 3 of its Medical Countermeasures Program. NOTE: The deadline for submission of EOIs has now passed. Further enquiries can be submitted by email
The CEO of the DMTC, Dr Mark Hodge, appeared before the joint parliamentary inquiry into ‘The benefits and risks of a Bipartisan Australian Defence Agreement as a basis of planning for, and funding of, Australian Defence capability’ on 23 February. Dr Hodge’s opening statement to the committee is available here.
DMTC is proud to announce the release of its latest Annual Report, which is available online and is currently being distributed to key stakeholders.
The report summarises the activities and achievements of the DMTC community for the July 2016 – June 2017 period and highlights continuing efforts to deliver enhanced Defence capabilities while also investing in Australian industrial capacity and in the research leaders of the future.
Our report also looks forward to opportunities and strategic developments for DMTC and its industry and research partners in 2018 and beyond.